GS-3583

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-3583, covering 2024-09-03 to 2024-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors [Phase 1]